1.5(top 11%)
Impact Factor
1.7(top 11%)
extended IF
41(top 10%)
H-Index
71
authors
166
papers
3.7K
citations
345
citing journals
747
citing authors

Most Cited Articles of Journal of Drug Assessment

TitleYearCitations
The National Association of Specialty Pharmacy Abstract Program201978
Variation in health plan specialty drug coverage: an empirical analysis201978
Coupling patient care management operations with technology and data platform to optimize hepatitis C therapy outcomes201978
Determining specialty pharmacy FTEs (full-time equivalents) needed in a clinical practice201978
Real-world assessment of an integrated clinical model on oral hepatitis C therapy at Southern Ohio Medical Center201978
Development of a specialty pharmacy productivity benchmarking model201978
Impact of multidisciplinary patient education sessions on expectations and understanding of new calcitonin gene-related peptide treatments201978
Impact of outpatient specialty pharmacy on medication adherence in post-kidney transplant patients201978
Impact of a high-touch, collaborative, patient-centric, hepatitis C specialty clinical program on completion of glecaprevir/pibrentasvir therapy201978
Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks201978
Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy201978
Medication adherence and graft survival among kidney transplant recipients201978
Medication adherence and graft survival among heart transplant recipients201978
United States health plan cancer concerns in 2019201978
Impact of a specialty pharmacy benefit on rheumatoid arthritis medication adherence and functional status: a continuation study201978
Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients201978
Appropriate prescribing of antiemetics with oral oncolytic therapy: a single center experience201978
Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic201978
Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database201978
Clinical impact of pharmacist interventions on improving outcomes in patients receiving immune globulin therapy in a home setting201978
Development of a palivizumab specialty pharmacy management program201978
Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks201978
Cost of leukopenia and neutropenia in metastatic breast cancer within last 12, 36, and 60 months using a curated disease model201978
Integrating high touch specialty pharmacy services within a neurology clinic to improve medication access and affordability201978
Implementation of an internal check of oral oncolytics: a single-center, specialty pharmacy safety initiative201978